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hhrichiu cofigyrA43 and g-w-f3203 alleles conferring temperature-sensitive (ts) growth encoded Gly75’~Asp and Pro”‘-&r substitutions in the 
DNA Byrase A and B subunits, respectively. A plasmid-borne g~r/143 allele was genetically dominant over a chromosomol quinolone-resistantgyrA 
gene at 30°C but no1 at 42°C. These rcsulu and others confirm the ts phcnotypc of the mutation, the first to be idendlied in the C-terminal DNA 
binding/complex stubilizing domain of gyrasc A protein. By contrast, the Pro”‘+Ser mutation is located near the ATP-binding site of gyrate B 
protein and could interfere with energy coupling during DNA supercoiling. These data are discussed in regard to rccmtly described gala 
mutations that affect the control of chromosome scgregalion. 
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1. INTRODUCTION 
Eschericha coii DNA gyrase is an AzBz tetramer en- 
coded by gy~‘A and gyB genes that catalyzes ATP- 
dependent DNA supercoiling and the formation and 
reso!ution of knotted and catenated DNA rings [l-3]. 
Studies of temperature-sensitive (ts) gyr.4 and gyrB 
strains have shown that gyrase is essential for bacterial 
growth, with roles in DNA replication, chromosome 
segregation and transcription [4-61. The enzyme acts by 
passing a DNA seb?nent through a transient double- 
stranded break in DNA [7]. The 97 kDa GyrA subunits 
mediate transient DNA breakage-reunion, a reaction 
interrupted by the 4-quinolone class of antimicrobial 
agents [S]. The 90 kDa GyrB subunits bind and hydro- 
lyze ATP and are inhibited by coumarin antibiotics uch 
as novobiocin and coumermycin [9]. Mutations confer- 
ring quinolone and coumarin drug resistance map pre- 
dominantly in the gyrA and gyrB genes, respectively 
[i3-143. 
protein generates two fragments: a 64 kDa N-terminal 
segment containing catalytic Tyr’” [20] and which car- 
ries the DNA breakage:Teunion functions, and a 33 
kDa C-terminal fragment ?hat binds DNA and appears 
to stabilize the enzyme complex with DNA [16-l& 
Studies of drug-gyrase interactions and identification of 
resistance mutations in gyrase genes have provided use- 
ful information, but this is restricted to those subunit 
domains involved in drug action. Given these limita- 
tions, we have sought to understand gyrase function by 
characterizing other novel mutations affecting enzyme 
activity. We have focussed on the thermoscnsitive E.
coli strains, KNK453 and N4177, whose respective 
GyrA and GyrB proteins are active at 30°C but inactive 
at 42’C [4,21,22]. Here we report the sequence of the 
KNK453 gyrA and N4177 gyrB genes, identification of 
the ts mutations, and genetic studies of the gyrA43 al- 
lele. 
Several lines of evidence indicate that the E. coii 
GyrA and GyrB proteins are.folded into domains with 
discrete functions [2,15-191. A 50 kDa C-terminal GyrB 
fragment binds GyrA to reconstitute the DNA relaxa- 
tion and cleavage activities of DNA gyrase but not 
DNA supercoiling [IS]. The ATP binding site lies in the 
43 kDa N-terminal GyrB fragment whose crystal struc- 
ture was recently determined at high resolution [19]. 
Trypsin cleavage at residue 571 of the 875 residue GyrA 
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2. I. Pulytnrrase chitr reucriutt cwd DNA sq~~errcc UIIU!,%~.S 
E, cali K-12 strains KNK4S3 IS)‘rA43(ts) F- potA I/@ mrA phx] 
and N4177 [strA gu! gmY2221 (cou”) gyrB203 Us)] were from K. 
Kreuz.er and M. Gcllert, respectively. The KNK453 gjjrA gcnc was 
isolakxl in four segments by PCR using four pain of olipnucleotides 
and KNK453 cells as the source of DNA. PCR primers and reaction 
conditions. restriction digestion of DCR prodkts and subsequent 
cloning oI’rragments into Ml3mpl8 and Ml 3mpl9 for scqucnce anal- 
ysis were as described previously in the analysis of the DM750 g_wA 
gene [?3]. For each fraagmcnt, recombinant clones derived from al least 
two indcpcndent PCR reactions wcrc sequenced by the didcoxychain- 
termination method [24] using the Scqucnasc version 3.0 protocol 
(United States Biochemicals). DNA sequences obtained for each com- 
plementary strand of the gene were in agreement. 
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The N4l77 g)jrB gene was iso!ated similarly as a 1.2 kb PCH prod- 
uct using oligonucleotide primers 5’ GATTAACCCAAGCTTAA 
ATGAGCCP (nucleotidc positions -34 to -11, an artificial Hlrldlll 
site is underlined) [25] and 5’ CGAGCGCACCTFTACGGCGG 
(1,195-1,176). DNA was digested with WrdIll and Cicd, re-cut at a 
unique internal &/II site, and the fragments cloned into Ml3mpl8 
and Ml3mpl9 for DNA sequence analysis. 
2.2. Cotlsrnrctiwl oJplmrrtid pM013 brnrirrg a gyrA (ts) gerw 
Amps plasmid pRM386 containing u wild-type g.w+A g,enc was 
kindly provided by Rolf Menrel [26]. The following procedure was 
used to construct pMO43 carrying the gyrA43(ts) allele. Plasmid 
pRM38G DNA lacking the KpnI-.S!raBI g~r.4 fragment was isolated 
by partial S/raBI digestion f KpnI-cut plasmid and elcctrophoresis in 
2% low gelling agarosc. The DNA was ligated to the corresponding 
KNK453 KpnI-SanDI g.vvrA fragment obtained from an M 13 replica- 
tive form clone of PRC product D [23] which bad been fully sequenced 
and shown to encode lhe putative ts mutation. Recombinant products 
\vcre transformed into J!?, cofi DHS (srrpE44 /&?I7 IWAI wfA I 
gyrA9B r&-l reIA1). Plasmids were isoluted and characterized by rem 
striction digestion with @III, SnrrBl, Hiad and &/l!. One plasmid. 
pM043, gave identical restriction digests to pR1M386, suggesting as- 
sembly of a functional gyrA43 allele. This plasmid isolate was used to 
transform KNK453 to ampicillin rcsistunce. 
2.3. Ductrrid groivtil 
Bacterial cultures were grown in L-broth at 30°C. Cleared lysatcs 
were prepared identically by lysozymc trcntment of bacteria grown to 
lop phase (ODbg, = 1.0) at 30°C as described previously [27]. Growth 
of KNK453 and its transformants was tested by spotting cultures (10 
,uI) on to H-plates containing 50 jr@rnl ampicillin and incubating 
overnight at 30 or 42°C. For similnr experiments involving DH5, 
H-plates contuining 100 j&/ml nalidixic ucid and SO yg/ml ampicillin 
were used. 
3. RESULTS 
3.1. Tetnpercmre-semitive mrrarions in E. coli gyrA arrd 
gYrD 
The nucleotide sequence of the entire KNK453 gyrA 
gene and promoter was determined and found to be 
identical to that reported for the wild type E. coli Kl2 
gene [28] except for one nuclcotide change: a G+A 
transition at nucleotide 2,252 that produces a 
Gl~‘~‘+Asp substitution in the KNK453 GyrA protein. 
There were no other changes in the KNK453 gene or 
its promoter. The observed nucleotide transition is con- 
sistent with the 2-aminopurine mutagenesis protocol 
originally used in deriving KNK453 [5,29]. In contrast, 
N4177 gyv5 exhibited two coding changes compared to 
the wild-type gene [2S]: CGC+TGC and CCC+TCC 
changes at nucleotides 406 and 511, generating 
Arg’“%Cys and Pro”‘+Ser substitutions in GyrQ, re- 
spectively. The Arg’36+Cys substitution is known to 
confer coumarin resistance [11,12] implying that the 
thermosensitivity of N4177 GyrB arises from mutation 
of Dro171. This analysis is consistent with the observa- 
tion that coumrrmycin resistance and thermosensitivity 
of N4177 arise from two different but closely linked 
mutations in gyrB [21]. The same nucleotide changes in 
N4177 g.yrB have recently been reported independently 
[12]. 
3.2, GIy?“+Asp GyrA mrrtation u/orze confers IS plreno- 
[YPe 
To facilitate genetic analysis, the KNK453 gyyrA gene 
was assembled byexchanging a KprzI-SnaBl gym frag 
merit bearing the gyuA43 mutation with its counterpart 
in the wild-type gyrA gene of plasmid pRM386 (Fig. 1) 
[lo]. KNK453, transformed with the resulting plasmid 
pM043, grew at 30 but not at 42OC, in contrast to 
KNK453 (pRM386) which grew at both temperatures 
(Fig. 2a). Only KNK453 (pRM386) over-expressed a 
100 kDa protein (Fig. 2b), previously identified as 
GyrA by using a polyclonal anti-GyrA antiserum (not 
shown). The results suggested that the Gly7S’~Asp 
GyrA protein is temperature s nsitive and is unstable in 
KNK453 cells even at 30°C. 
3.3. gyrA”-gyrAjr- aj dmzitmse studies: effects of COPY 
nutttber 
Conclusive evidence for the thermosensitivity of the 
recombinant KNK453 GyrA protein was obtained by 
exploiting the observation that (in meridiploid E. coli 
strains) quinoione-sensitive JIJY~A alleles are dominant 
over drug-resistant alleles [30]. This dominance is 
thought to arise because quinolones kill bacteria bj, 
trapping gyrase complexes on DNA [IO]. In agreement 
with this idea, pRM386 blocked nalidixic acid-resistant 
growth of E. coli DH5 gYrA” at both 30 and 42°C (Fig. 
.?a). However, transformation with pMO43 rendered 
DH5 drug sensitive at 30°C but drug resistant at 42°C. 
This behaviour is consistent with expression of the qui- 
ll 
pRM386 
9.2 kb 
Fig. 1. Restriction map oTgyrA plasmid pRM386 and its use in the 
expression of the KNK453 g+rrA Bcnc. B, H, K and S arc sites for 
g/ii, HhdllI, K~~rrl and %rrBl, respectively. Arrows. indicate amp 
and wild-type .gyTri genes. Bxchangc of the Kpr:-SdX gym,4 fiag- 
men1 (Bllcd) with its KNK453 counterpart encoding a Gly’$‘+Asp 
GyrA mutation generated plasmid pM043 which expressed the 
gyrA43 allele, 
62 
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Fig. 2. Growth properties of E. coli KNK453 transformed with plasmid pRM386 or pM043 bearing wild-type gyrrl or gyrA43 alleles. (A) 
Temperature-sensitive growth of KNK453 at 42%Z is rescued by transformation with pRM386 but not by pM043. Bacterii were spotted on 
ampicillin plates and incubated overnight. (B) GyrA protein, indicated by the arrowhead, is over-cxpressd in KNK453 (pRM386) but not in 
KNK453 (pM043) cells. Bacterial ysntes (20 ,ug protein) from KNK453. KNK453 (pRM38G) and KNK4S3 (pMO43) were run on a 7% 
SDS-polyacrylamide gel (lanes ax, respectively). 
nolonc- and temperature-sensitive gyrA gene from 
pM043, confirmed by analysis of protein extracts (Fig. 
3b). 
Previous studies have shown that plasmid-borne qui- 
nolone-resistant gyrA genes act dominantly over the 
chromosomal gyrA43 allele in KNK453 or the related 
strain KNK402 ([10,14] and refs. therein). Thus, the 
outcome of dominance tests between gyrA” and gyr&tsj 
alleles appears to depend on their relative levels of ex- 
pression. 
4. DISCUSSION 
We have identified two mutations in ts Syrase Scenes, 
one in gyrA and one in gyrf#. These mutations result in 
Gly’“‘+Asp and Pro’%Ser changes in the respective 
GyrA and GyrB proteins. The ts phenotype of the 
Gly75’+Asp mutation was confirmed directly by exam- 
ining the genelic properties of the gyA43 a!!e!e ex- 
pressed from a high copy plasmid. As expected, the 
plasmid borne is allele was dominant over a quinolone- 
63 
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Fig. 3. The gym43 allule over-expressed in quinolonc-resistant E. coli DH5 exerts a dominant quinolone-sensitive phenotype. (A) pM043 confers 
nalidixic acid sensitivity on Dl-15 al 30 bur not at 4PC. The wild-type g?lrA gene on pRM386 blocked DHS growth at both temperatures. DH5 
cells transformed with the curtl) plasmid, pBR322, lacking a gJ’,‘A gene were resistant to nalidixic acid. Plates contained ampicillin and nalidixic 
acid. (B) GyrA protein is over-expressed from pl~mid pM043 in E. co/i DHS. Bacterial lysates of DH5, DHT(pM043) and DH5 (pRM386) were 
run on a 7.5% SDS-polyacrylamide gel (lanes a-c, respectively). 
resistant chromosomal gyr,4 allele in a quinolone sensi- 
tivity assay at 30°C but not at 42°C (Fig. 3a). Surpris- 
ingly, when the plasmid and chromosomal locations of 
the two alleles are reversed, then the plasmid gyrA” gene 
becomes dominant over g~~r,443 even at the permissive 
temperature [10,14]. Under the latter conditions, it 
would seem that a large excess of resistant GyrA sub- 
units produced by the high copy plasmid is able to 
sequester the limited amount of available GyrB protein 
yielding predominantly drug-resistant gyrase com- 
plexes. Another contributory Factor could be the lower 
basal evel of host GyrA protein observed in KNK453 
cells [4], perhaps reflecting the apparent instability of 
the Gly7si+A~p rotein even at 30°C (Figs. 2b, 3b). 
These results highlight the need to consider copy num- 
ber effects in gyrAn-gyrA(ts) dominance studies. 
How do ts mutations in gyrase result in theimolabi!e 
enzyme activity? Studies of ts mutations in other sys- 
tems have identified a variety of structural alterations. 
Recent work has shown that thermolability can often 
64 
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ensue from substitution of a proline residue located in 
a turn motif [31]. Consistent with this observation, we 
note from the crystal structure of the 43 kDa N-terminal 
GyrB fragment, hat the Pro”‘+Ser mutation in N4177 
GyrB lies at a turn of the polypeptide chain at the 
C-terminal end of a /? strand 1191. Thus, although the 
full gyrB sequence was not determined, these results 
strongly suggest hat the mutation at Pro”’ confers the 
ts phenotype of N4177. Residue 171 is adjacent o, but 
not part of, the ATP binding site and its mutation to Ser 
could act by disrupting ATP utilization by gyrase at the 
non-permissive t mperature. 
The ts mutation in KNK453 GyrA substitutes GIY~~’ 
in a highly conserved sequence (Thr-Glu-Asn-Gly- 
Tyr-Gly-Lys-Arg-Thr) which is predicted to form a B 
turn (not shown). The mutation is the first to be re- 
ported in the 33 kDa C-terminal segment of GyrA pro- 
tein, a DNA binding domain that stabilizes the gyrase 
complex on DNA [18]. Substitution of a flexible glycine 
with the negatively charged aspartate residue could af- 
fect DNA binding by the complex. These ideas are spec- 
ulative in the absence of high resolution X-ray data for 
GyrA protein. However, the KNK453 GyrA mutation 
should provide a novel probe with which to investigate 
the functions of the DNA binding GyrA domain. 
Finally, ts mutations in gyrase genes have attracted 
recent attention in the context of chromosomal segrega- 
tion. Miki et al. [32] have identified several E. cofi muta- 
tions which suppress growth inhibition by the sex factor 
F IetD gene, the protein product of which inhibits parti- 
tioning of chromosomal DNA and host cell division. 
One mutation, rldC15, specified a Gly”‘+Glu substitu- 
tion in GyrA and conferred a dual phenotype: Lolerance 
to letD product growth inhibition in a host carrying an 
F&A-mutant, and ts growth at 42OC. The r/K muta- 
tion (likegyr.443) involves ubstitution of a glycine with 
an acidic residue, but lies in the DNA breakage-reunion 
domain of the A protein. Surprisingly, the gJjrA42(ts) 
mutation (isolated with g~~A43 and gyrA45 by a com- 
pletely different proccudre [12]), but not a gJjrB(ts) mu- 
tation, had the same phenotype as 1ldCl5. These results 
suggested that GyrA is the direct (or indirect) target of 
the IetD protein, and that certain (ts) mutations in 
GyrA, e.g. gyrA42, are able to suppress the biological 
effects of this interaction. The availability of gyrase ts 
alleles, particularly those such as gyrA43 for which the 
mutational basis is known, may prove useful in further 
defining the gyrase-1etD protein interaction and the 
role of gyrase in chromosome partitioning. 
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